Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1976-01-26
1977-07-05
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 232306, 252447, 424 12, G01N 3300, G21H 502, B01J 122
Patent
active
040340716
ABSTRACT:
The technique of separating a tagged bound material from the same unbound material in immunoassay procedures is improved by utilizing a clathrate sorbent to carry out the separation. A clathrate sorbent, for example, comprises a mixture of hydrate zinc sulfate and sodium hydroxide which form an inclusion compound with charcoal powder. Charcoal powder has also been combined to form a clathrate sorbent with salts of other metals which produce a gelatinous substance with alkaline hydroxides; e.g., alum with sodium hydroxide. Another example of a clathrate sorbent is magnesium trisilicate combined with the aforementioned zinc preparation.
REFERENCES:
patent: 1519470 (1924-12-01), Wilson et al.
patent: 2112931 (1938-04-01), Schulze
patent: 2470688 (1949-05-01), Carter
patent: 3442819 (1969-05-01), Herbert
patent: 3666854 (1972-05-01), Eisentraut
patent: 3768979 (1973-10-01), Mead et al.
patent: 3816076 (1974-06-01), Backer
patent: 3843775 (1974-10-01), Wolf
patent: 3896217 (1975-07-01), Johnson
Allegheny General Hospital
Nucker Christine M.
Padgett Benjamin R.
LandOfFree
Immunoassay procedures does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunoassay procedures, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoassay procedures will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-578149